KYAN Technologies
KYAN Technologies is a Singapore-based precision-medicine company and a pioneering leader in functional precision medicine for oncology.
- Headquarters
- Singapore 338729
- Founded
- 2022
What we do
KYAN Technologies is a Singapore-based precision-medicine company and a pioneering leader in functional precision medicine for oncology. Using its Optim.AI platform, the company predicts personalised cancer treatments by testing combinatorial drug sensitivity, delivering clinical decision support to oncologists. Beyond clinical support, KYAN offers biopharma R&D services to help accelerate drug development. Its technology, originally developed at UCLA and the National University of Singapore, combines advanced analytics with laboratory testing to optimise treatment decisions. By enabling more personalised, data-driven cancer care and faster drug development, KYAN aims to improve outcomes for patients and biopharma partners. The company positions itself as an innovator in functional precision oncology.
How we deliver
- functional precision medicine
- clinical decision support
- oncology
Company history
KYAN Technologies was founded in 2022.
Locations
Headquarters: Singapore 338729